Search Reports
Categories
Categories

Global Pentavalent Vaccine Market

Global Pentavalent Vaccine Market Research Report 2025(Status and Outlook)

Report Code : PHA2572
Published Date : 17 July, 1905 | No of Pages: 132

  • Report Description
  • Table of Contents
  • Companies Mentioned
  • Related Reports


Report Overview
The pentavalent vaccine is a combination immunization that protects against five potentially life-threatening diseases: diphtheria, tetanus, pertussis (whooping cough), hepatitis B, and Haemophilus influenzae type b (Hib). By bundling these vaccines into a single shot, it simplifies immunization schedules, reduces the number of injections required, and improves vaccination coverage, particularly in low- and middle-income countries where healthcare access may be limited. The vaccine plays a critical role in global immunization programs, supported by organizations like Gavi, the Vaccine Alliance, which helps fund its distribution in developing nations. Demand for pentavalent vaccines is driven by national immunization programs, growing awareness of preventable diseases, and government initiatives to reduce child mortality. Key manufacturers include Serum Institute of India, Sanofi, and Bharat Biotech, with competition focused on cost efficiency, supply reliability, and adherence to WHO prequalification standards. The market faces challenges such as cold chain logistics, vaccine hesitancy, and funding constraints, but expansion in emerging economies and advancements in vaccine delivery systems present significant growth opportunities.

The global Pentavalent Vaccine market size was estimated at USD 1347.15 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 5.25% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Pentavalent Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Pentavalent Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Pentavalent Vaccine market.
Global Pentavalent Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Serum Institute of India
Panacea Drugs Pvt. Ltd
Shantha Biotechnics
Biological E. Ltd.
Novartis AG
Crucell
Bio Farma

Market Segmentation (by Type)
Lyophilized
Liquid

Market Segmentation (by Application)
Retail Pharmacy
Hospital Pharmacy
E-commerce

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Pentavalent Vaccine Market
Overview of the regional outlook of the Pentavalent Vaccine Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pentavalent Vaccine Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market\'s competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter\'s five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Pentavalent Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



  Table of Contents
  1 Research Methodology and Statistical Scope
      1.1 Market Definition and Statistical Scope of Pentavalent Vaccine
      1.2 Key Market Segments
            1.2.1 Pentavalent Vaccine Segment by Type
            1.2.2 Pentavalent Vaccine Segment by Application
      1.3 Methodology & Sources of Information
            1.3.1 Research Methodology
            1.3.2 Research Process
            1.3.3 Market Breakdown and Data Triangulation
            1.3.4 Base Year
            1.3.5 Report Assumptions & Caveats
  2 Pentavalent Vaccine Market Overview
      2.1 Global Market Overview
            2.1.1 Global Pentavalent Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
            2.1.2 Global Pentavalent Vaccine Sales Estimates and Forecasts (2020-2033)
      2.2 Market Segment Executive Summary
      2.3 Global Market Size by Region
  3 Pentavalent Vaccine Market Competitive Landscape
      3.1 Company Assessment Quadrant
      3.2 Global Pentavalent Vaccine Product Life Cycle
      3.3 Global Pentavalent Vaccine Sales by Manufacturers (2020-2025)
      3.4 Global Pentavalent Vaccine Revenue Market Share by Manufacturers (2020-2025)
      3.5 Pentavalent Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
      3.6 Global Pentavalent Vaccine Average Price by Manufacturers (2020-2025)
      3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
      3.8 Pentavalent Vaccine Market Competitive Situation and Trends
            3.8.1 Pentavalent Vaccine Market Concentration Rate
            3.8.2 Global 5 and 10 Largest Pentavalent Vaccine Players Market Share by Revenue
            3.8.3 Mergers & Acquisitions, Expansion
  4 Pentavalent Vaccine Industry Chain Analysis
      4.1 Pentavalent Vaccine Industry Chain Analysis
      4.2 Market Overview of Key Raw Materials
      4.3 Midstream Market Analysis
      4.4 Downstream Customer Analysis
  5 The Development and Dynamics of Pentavalent Vaccine Market
      5.1 Key Development Trends
      5.2 Driving Factors
      5.3 Market Challenges
      5.4 Industry News
            5.4.1 New Product Developments
            5.4.2 Mergers & Acquisitions
            5.4.3 Expansions
            5.4.4 Collaboration/Supply Contracts
      5.5 PEST Analysis
            5.5.1 Industry Policies Analysis
            5.5.2 Economic Environment Analysis
            5.5.3 Social Environment Analysis
            5.5.4 Technological Environment Analysis
      5.6 Global Pentavalent Vaccine Market Porter's Five Forces Analysis
            5.6.1 Global Trade Frictions
            5.6.2 U.S. Tariff Policy – April 2025
            5.6.3 Global Trade Frictions and Their Impacts to Pentavalent Vaccine Market
      5.7 ESG Ratings of Leading Companies
  6 Pentavalent Vaccine Market Segmentation by Type
      6.1 Evaluation Matrix of Segment Market Development Potential (Type)
      6.2 Global Pentavalent Vaccine Sales Market Share by Type (2020-2025)
      6.3 Global Pentavalent Vaccine Market Size Market Share by Type (2020-2025)
      6.4 Global Pentavalent Vaccine Price by Type (2020-2025)
  7 Pentavalent Vaccine Market Segmentation by Application
      7.1 Evaluation Matrix of Segment Market Development Potential (Application)
      7.2 Global Pentavalent Vaccine Market Sales by Application (2020-2025)
      7.3 Global Pentavalent Vaccine Market Size (M USD) by Application (2020-2025)
      7.4 Global Pentavalent Vaccine Sales Growth Rate by Application (2020-2025)
  8 Pentavalent Vaccine Market Sales by Region
      8.1 Global Pentavalent Vaccine Sales by Region
            8.1.1 Global Pentavalent Vaccine Sales by Region
            8.1.2 Global Pentavalent Vaccine Sales Market Share by Region
      8.2 Global Pentavalent Vaccine Market Size by Region
            8.2.1 Global Pentavalent Vaccine Market Size by Region
            8.2.2 Global Pentavalent Vaccine Market Size Market Share by Region
      8.3 North America
            8.3.1 North America Pentavalent Vaccine Sales by Country
            8.3.2 North America Pentavalent Vaccine Market Size by Country
            8.3.3 U.S. Market Overview
            8.3.4 Canada Market Overview
            8.3.5 Mexico Market Overview
      8.4 Europe
            8.4.1 Europe Pentavalent Vaccine Sales by Country
            8.4.2 Europe Pentavalent Vaccine Market Size by Country
            8.4.3 Germany Market Overview
            8.4.4 France Market Overview
            8.4.5 U.K. Market Overview
            8.4.6 Italy Market Overview
            8.4.7 Spain Market Overview
      8.5 Asia Pacific
            8.5.1 Asia Pacific Pentavalent Vaccine Sales by Region
            8.5.2 Asia Pacific Pentavalent Vaccine Market Size by Region
            8.5.3 China Market Overview
            8.5.4 Japan Market Overview
            8.5.5 South Korea Market Overview
            8.5.6 India Market Overview
            8.5.7 Southeast Asia Market Overview
      8.6 South America
            8.6.1 South America Pentavalent Vaccine Sales by Country
            8.6.2 South America Pentavalent Vaccine Market Size by Country
            8.6.3 Brazil Market Overview
            8.6.4 Argentina Market Overview
            8.6.5 Columbia Market Overview
      8.7 Middle East and Africa
            8.7.1 Middle East and Africa Pentavalent Vaccine Sales by Region
            8.7.2 Middle East and Africa Pentavalent Vaccine Market Size by Region
            8.7.3 Saudi Arabia Market Overview
            8.7.4 UAE Market Overview
            8.7.5 Egypt Market Overview
            8.7.6 Nigeria Market Overview
            8.7.7 South Africa Market Overview
  9 Pentavalent Vaccine Market Production by Region
      9.1 Global Production of Pentavalent Vaccine by Region(2020-2025)
      9.2 Global Pentavalent Vaccine Revenue Market Share by Region (2020-2025)
      9.3 Global Pentavalent Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
      9.4 North America Pentavalent Vaccine Production
            9.4.1 North America Pentavalent Vaccine Production Growth Rate (2020-2025)
            9.4.2 North America Pentavalent Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
      9.5 Europe Pentavalent Vaccine Production
            9.5.1 Europe Pentavalent Vaccine Production Growth Rate (2020-2025)
            9.5.2 Europe Pentavalent Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
      9.6 Japan Pentavalent Vaccine Production (2020-2025)
            9.6.1 Japan Pentavalent Vaccine Production Growth Rate (2020-2025)
            9.6.2 Japan Pentavalent Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
      9.7 China Pentavalent Vaccine Production (2020-2025)
            9.7.1 China Pentavalent Vaccine Production Growth Rate (2020-2025)
            9.7.2 China Pentavalent Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
  10 Key Companies Profile
      10.1 Serum Institute of India
            10.1.1 Serum Institute of India Basic Information
            10.1.2 Serum Institute of India Pentavalent Vaccine Product Overview
            10.1.3 Serum Institute of India Pentavalent Vaccine Product Market Performance
            10.1.4 Serum Institute of India Business Overview
            10.1.5 Serum Institute of India SWOT Analysis
            10.1.6 Serum Institute of India Recent Developments
      10.2 Panacea Drugs Pvt. Ltd
            10.2.1 Panacea Drugs Pvt. Ltd Basic Information
            10.2.2 Panacea Drugs Pvt. Ltd Pentavalent Vaccine Product Overview
            10.2.3 Panacea Drugs Pvt. Ltd Pentavalent Vaccine Product Market Performance
            10.2.4 Panacea Drugs Pvt. Ltd Business Overview
            10.2.5 Panacea Drugs Pvt. Ltd SWOT Analysis
            10.2.6 Panacea Drugs Pvt. Ltd Recent Developments
      10.3 Shantha Biotechnics
            10.3.1 Shantha Biotechnics Basic Information
            10.3.2 Shantha Biotechnics Pentavalent Vaccine Product Overview
            10.3.3 Shantha Biotechnics Pentavalent Vaccine Product Market Performance
            10.3.4 Shantha Biotechnics Business Overview
            10.3.5 Shantha Biotechnics SWOT Analysis
            10.3.6 Shantha Biotechnics Recent Developments
      10.4 Biological E. Ltd.
            10.4.1 Biological E. Ltd. Basic Information
            10.4.2 Biological E. Ltd. Pentavalent Vaccine Product Overview
            10.4.3 Biological E. Ltd. Pentavalent Vaccine Product Market Performance
            10.4.4 Biological E. Ltd. Business Overview
            10.4.5 Biological E. Ltd. Recent Developments
      10.5 Novartis AG
            10.5.1 Novartis AG Basic Information
            10.5.2 Novartis AG Pentavalent Vaccine Product Overview
            10.5.3 Novartis AG Pentavalent Vaccine Product Market Performance
            10.5.4 Novartis AG Business Overview
            10.5.5 Novartis AG Recent Developments
      10.6 Crucell
            10.6.1 Crucell Basic Information
            10.6.2 Crucell Pentavalent Vaccine Product Overview
            10.6.3 Crucell Pentavalent Vaccine Product Market Performance
            10.6.4 Crucell Business Overview
            10.6.5 Crucell Recent Developments
      10.7 Bio Farma
            10.7.1 Bio Farma Basic Information
            10.7.2 Bio Farma Pentavalent Vaccine Product Overview
            10.7.3 Bio Farma Pentavalent Vaccine Product Market Performance
            10.7.4 Bio Farma Business Overview
            10.7.5 Bio Farma Recent Developments
  11 Pentavalent Vaccine Market Forecast by Region
      11.1 Global Pentavalent Vaccine Market Size Forecast
      11.2 Global Pentavalent Vaccine Market Forecast by Region
            11.2.1 North America Market Size Forecast by Country
            11.2.2 Europe Pentavalent Vaccine Market Size Forecast by Country
            11.2.3 Asia Pacific Pentavalent Vaccine Market Size Forecast by Region
            11.2.4 South America Pentavalent Vaccine Market Size Forecast by Country
            11.2.5 Middle East and Africa Forecasted Sales of Pentavalent Vaccine by Country
  12 Forecast Market by Type and by Application (2026-2033)
      12.1 Global Pentavalent Vaccine Market Forecast by Type (2026-2033)
            12.1.1 Global Forecasted Sales of Pentavalent Vaccine by Type (2026-2033)
            12.1.2 Global Pentavalent Vaccine Market Size Forecast by Type (2026-2033)
            12.1.3 Global Forecasted Price of Pentavalent Vaccine by Type (2026-2033)
      12.2 Global Pentavalent Vaccine Market Forecast by Application (2026-2033)
            12.2.1 Global Pentavalent Vaccine Sales (K MT) Forecast by Application
            12.2.2 Global Pentavalent Vaccine Market Size (M USD) Forecast by Application (2026-2033)
  13 Conclusion and Key Findings
Serum Institute of India
Panacea Drugs Pvt. Ltd
Shantha Biotechnics
Biological E. Ltd.
Novartis AG
Crucell
Bio Farma
Please select License
Single User Price:$ 3200
Site License Price:$ 6400
Enterprise Price:$ 6400